Long-term DPP4-inhibitor use not tied to fracture risk in T2DM
(HealthDay)—Patients with diabetes often have fractures, but sitagliptin is not associated with increased fracture risk, according to a study published online Sept. 8 in Diabetes, Obesity and Metabolism.